Valeo Pharma Inc. (VPHIF)

Valeo Pharma Balance Sheet

Financials in millions CAD. Fiscal year is November - October.

Assets

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jul 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019
Cash & Equivalents	7.13	7.5	22.5	2.04	2.84	0.34
Cash & Short-Term Investments	7.13	7.5	22.5	2.04	2.84	0.34
Cash Growth	-27.12%	-66.66%	1001.37%	-27.96%	746.57%	2945.45%
Accounts Receivable	4.59	6.42	5.23	1.47	1.01	0.38
Other Receivables	0.19	0.14	0.2	0.32	0.21	0.23
Receivables	4.78	6.57	5.43	1.8	1.22	0.61
Inventory	6.71	10.25	9.98	7.68	0.88	0.56
Prepaid Expenses	0.45	0.93	0.61	0.83	0.47	0.14
Other Current Assets	-	-	2.01	-	-	-
Total Current Assets	19.06	25.24	40.53	12.35	5.41	1.65
Property, Plant & Equipment	2.47	2.66	2.25	2.14	0.61	0.3
Other Intangible Assets	9.8	11.7	13.61	3.73	2.2	1.98
Long-Term Deferred Charges	0.87	1.6	1.87	2.81	2.75	1.88
Total Assets	32.2	41.21	58.27	21.03	10.96	5.81

Liabilities

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jul 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019
Accounts Payable	10.09	3.99	3.74	7.32	3.38	3.84
Accrued Expenses	2.98	2.4	6.52	0.37	0.12	0.04
Short-Term Debt	3.41	2.79	-	-	-	-
Current Portion of Long-Term Debt	42.17	1.81	0.74	4.85	-	-
Current Portion of Leases	0.06	0.07	0.05	0.05	0.06	-
Other Current Liabilities	11.2	9.21	4.29	2.75	0.72	0.6
Total Current Liabilities	69.91	20.27	15.34	15.33	4.28	4.48
Long-Term Debt	23.79	59.76	59.53	1.61	2.97	1
Long-Term Leases	1.29	1.34	1.11	1.17	0.23	-
Pension & Post-Retirement Benefits	0.24	0.18	0.13	0.29	0.42	0.35
Other Long-Term Liabilities	-	-	-	0.58	-	-
Total Liabilities	95.23	81.54	76.11	18.98	7.89	5.83

Shareholders' Equity

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jul 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019
Common Stock	31.83	31.7	26.36	24.62	15.02	8.83
Additional Paid-In Capital	4.72	4.58	4.41	2.4	1.61	0.59
Retained Earnings	-105.14	-82.26	-54.46	-28.71	-14.48	-9.72
Comprehensive Income & Other	5.56	5.65	5.84	3.75	0.91	0.27
Shareholders' Equity	-63.03	-40.34	-17.85	2.05	3.07	-0.02
Total Liabilities & Equity	32.2	41.21	58.27	21.03	10.96	5.81

Additional Metrics

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jul 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020	Oct 31, 2019
Total Debt	70.73	65.76	61.44	7.67	3.26	1
Net Cash (Debt)	-63.6	-58.26	-38.94	-5.63	-0.43	-0.67
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.72	-0.68	-0.48	-0.08	-0.01	-0.01
Filing Date Shares Outstanding	98.68	98.67	82.27	78.85	64.06	56.66
Total Common Shares Outstanding	98.68	98.63	82.19	78.8	64.06	56.66
Working Capital	-50.86	4.97	25.19	-2.98	1.13	-2.83
Book Value Per Share	-0.64	-0.41	-0.22	0.03	0.05	-0.00
Tangible Book Value	-72.84	-52.04	-31.46	-1.68	0.87	-2
Tangible Book Value Per Share	-0.74	-0.53	-0.38	-0.02	0.01	-0.04
Machinery	1.47	1.38	1.15	0.83	0.72	0.66
Leasehold Improvements	1.19	1.19	0.95	0.91	0.11	0.11

Data Source: S&P Global Market Intelligence Last updated: Jul 31, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error